Establishing therapeutic drug monitoring to routinely assess pharmacokinetic changes for psychotropic medications prescribed during pregnancy and lactation

Therapeutic drug monitoring (TDM) has been employed to assess alterations in pharmacokinetics of psychotropic medications due to the physiological changes of pregnancy over the past decades. Here we present an approach to quantify the pregnancy impact on the pharmacokinetics of antidepressants, lithium and antiseizure medications.